Jessica Shank Coviello, DNP, APRN, ANP-BC
Associate Professor of Nursing
Yale University School of Nursing
Next up in our video series, we have four new episodes packed with data and best practices on the incidence, mitigation, and management of cardiotoxicities associated with HER2-targeted therapies, immune checkpoint inhibitor therapies, kinase inhibitors, and novel immunotherapies. In these new videos, our section editors and I talk about patient risk factors, toxicity management strategies, and the importance of multidisciplinary practice.
We’re also excited to bring you updated drug class–specific news/literature articles and resources, providing cutting-edge data and information in the field of cardio-oncology.
ASCO Annual Meeting 2020 (Abstract/Poster)
2020 ASCO Annual Meeting (Abstract/Poster)
Frontiers in Pharmacology
Cancer Therapy Advisor
This activity is supported by Bristol-Myers Squibb and Pharmacyclics LLC.